Abstract
Increasing the size and strength of muscles represents a promising therapeutic strategy for musculoskeletal disorders, and interest has focused on myostatin, a negative regulator of muscle growth. Various myostatin inhibitor approaches have been identified and tested in models of muscle disease with varying efficacies, depending on the age at which myostatin inhibition occurs. Here, we describe a one-time gene administration of myostatin-inhibitor-proteins to enhance muscle mass and strength in normal and dystrophic mouse models for >2 years, even when delivered in aged animals. These results demonstrate a promising therapeutic strategy that warrants consideration for clinical trials in human muscle diseases.
Bibliography
Haidet, A. M., Rizo, L., Handy, C., Umapathi, P., Eagle, A., Shilling, C., Boue, D., Martin, P. T., Sahenk, Z., Mendell, J. R., & Kaspar, B. K. (2008). Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors. Proceedings of the National Academy of Sciences, 105(11), 4318â4322.
Authors
11
- Amanda M. Haidet (first)
- Liza Rizo (additional)
- Chalonda Handy (additional)
- Priya Umapathi (additional)
- Amy Eagle (additional)
- Chris Shilling (additional)
- Daniel Boue (additional)
- Paul T. Martin (additional)
- Zarife Sahenk (additional)
- Jerry R. Mendell (additional)
- Brian K. Kaspar (additional)
References
27
Referenced
217
10.1096/fj.02-1215rev
10.1083/jcb.200108071
10.1038/ng0997-71
10.1101/gr.7.9.910
10.1073/pnas.94.23.12457
10.1073/pnas.0408729102
10.1002/ana.10385
10.1038/387083a0
10.1146/annurev.cellbio.20.012103.135836
10.1038/nature01154
10.2353/ajpath.2006.051316
10.1038/nm1479
10.1073/pnas.151270098
10.1038/374360a0
10.1371/journal.pone.0000789
10.1038/sj.onc.1201807
10.1074/jbc.M006114200
10.1210/me.2002-0366
10.1212/01.wnl.0000215940.77382.67
10.1073/pnas.85.12.4218
10.1530/rep.0.1260133
10.1016/S0021-9258(18)82296-7
10.1210/endo-129-2-815
10.1096/fj.07-8673com
10.1016/j.ymthe.2005.04.001
10.1073/pnas.0705971104
10.1073/pnas.0609411103
Dates
Type | When |
---|---|
Created | 17 years, 5 months ago (March 11, 2008, 11:45 p.m.) |
Deposited | 3 years, 4 months ago (April 12, 2022, 4:13 p.m.) |
Indexed | 4 weeks, 1 day ago (July 30, 2025, 11:02 a.m.) |
Issued | 17 years, 5 months ago (March 18, 2008) |
Published | 17 years, 5 months ago (March 18, 2008) |
Published Online | 17 years, 5 months ago (March 18, 2008) |
Published Print | 17 years, 5 months ago (March 18, 2008) |
@article{Haidet_2008, title={Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors}, volume={105}, ISSN={1091-6490}, url={http://dx.doi.org/10.1073/pnas.0709144105}, DOI={10.1073/pnas.0709144105}, number={11}, journal={Proceedings of the National Academy of Sciences}, publisher={Proceedings of the National Academy of Sciences}, author={Haidet, Amanda M. and Rizo, Liza and Handy, Chalonda and Umapathi, Priya and Eagle, Amy and Shilling, Chris and Boue, Daniel and Martin, Paul T. and Sahenk, Zarife and Mendell, Jerry R. and Kaspar, Brian K.}, year={2008}, month=mar, pages={4318–4322} }